Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2025-12-24 @ 10:03 PM
NCT ID:
NCT02807935
Brief Summary:
The purpose of our current series of studies is to evaluate different glaucoma treatments in vivo effect on the conventional outflow pathway, and specifically on the Schlemm's canal (SC) anatomy using Enhanced Depth Imaging (EDI)-optical coherence tomography (OCT) . The images will be taken as part of the patients routine medical follow up (before starting the treatment, and 1,4 and 12 weeks afterwards) diameter, cross-sectional area and volume will be measured using commercially available 3-dimensional reconstruction.
The series of studies will be divided into 3 branches, each branch contains different treatments.For each treatment different patients will be recruited.
The branches are as following-
1. The surgical branch-
1. Before and after trabeculotomy
2. Before and after cataract surgery
3. Before and after vitrectomy surgery
4. Before and after XEN™ Gel Stent implant
2. The pharmacological branch-
1. Before and during the treatment with prostaglandins analogs
2. Before and during the treatment with alpha blockers
3. Before and during the treatment with beta blockers
4. Before and during the treatment with carbonic anhydrase inhibitor
3. The laser branch-
1. Before and after trabeculoplasty
2. Before and after laser iridotomy
3. Before and after yag capsulotomy laser
Study:
NCT02807935
Study Brief:
Protocol Section:
NCT02807935